Mirae Asset Global Investments
SRNE

Mirae Asset Global Investments’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Mirae Asset Global Investments’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,657,557
Closed -$1.47M – 2622
2022
Q4 		$1.47M Buy
1,657,557
+146,776
+10% +$195K ﹤0.01% 1299
2022
Q3 		$2.37M Buy
1,510,781
+175,710
+13% +$399K 0.01% 1067
2022
Q2 		$2.68M Buy
1,335,071
+429,224
+47% +$742K 0.01% 1048
2022
Q1 		$2.11M Sell
905,847
-149,396
-14% -$466K ﹤0.01% 1146
2021
Q4 		$4.91M Buy
1,055,243
+268,257
+34% +$1.67M 0.01% 890
2021
Q3 		$6M Buy
786,986
+154,327
+24% +$1.31M 0.02% 789
2021
Q2 		$6.13M Buy
632,659
+126,084
+25% +$1M 0.02% 767
2021
Q1 		$4.19M Buy
506,575
+231,840
+84% +$2.45M 0.01% 768
2020
Q4 		$1.88M Buy
274,735
+144,342
+111% +$1.16M 0.01% 950
2020
Q3 		$1.45M Buy
130,393
+41,683
+47% +$381K 0.01% 861
2020
Q2 		$557K Buy
88,710
+45,588
+106% +$175K ﹤0.01% 1104
2020
Q1 		$79K Buy
43,122
+4,813
+13% +$13.9K ﹤0.01% 1390
2019
Q4 		$129K Sell
38,309
-11,482
-23% -$27.4K ﹤0.01% 1455
2019
Q3 		$107K Buy
49,791
+36,801
+283% +$85.8K ﹤0.01% 1410
2019
Q2 		$35K Buy
+12,990
New +$46.7K ﹤0.01% 1385

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $56.9M AUM 80.32% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.04B AUM 17.78% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $470M AUM 15.4% 1-Year Est. Return

Mirae Asset Global Investments's SRNE Position: Q1 2023 in Review

Mirae Asset Global Investments sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 1,657,557 shares — an estimated $1.47M sold.

Mirae Asset Global Investments first reported a position in SRNE in Q2 2019 and held it in 15 quarters. The position peaked at $6.13M in Q2 2021. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • Mirae Asset Global Investments reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Mirae Asset Global Investments sold 1,657,557 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $1.47M.
  • Mirae Asset Global Investments first reported a position in Sorrento Therapeutics, Inc. in Q2 2019 and held it in 15 quarters.
  • Mirae Asset Global Investments's Sorrento Therapeutics, Inc. position peaked at $6.13M in Q2 2021.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Mirae Asset Global Investments's 13F filing for Q1 2023, filed 4 May 2023.